Skip to main content
. 2016 Aug 29;9:199–205. doi: 10.1016/j.dib.2016.08.039

Table 2.

Statistical analysis of Peak Flow Expiratory Rate in the morning and evening in the PD analysis set.

Morning QAW039 Placebo Treatment difference QAW039-placebo
Day
1 389.6 (377.9, 401.4) 382.8 (371.1, 394.4) 6.9 (−9.7, 23.4)NS
2 395.0 (382.9, 407.1) 398.8 (387.5, 410.0) −3.8 (−20.3, 12.8)NS
7 394.4 (382.9, 405.9) 388.6 (377.2, 400.0) 5.8 (−10.4, 22.0)NS
14 393.3 (381.4, 405.2) 389.8 (378.4, 401.2) 3.5 (−13.0, 20.0)NS
21 394.1 (381.9, 406.3) 391.5 (379.9, 403.1) 2.6 (−14.3, 19.5)NS
28 378.6 (366.3, 391.0) 382.8 (371.3, 394.4) −4.2 (−21.1, 12.7)NS



Evening QAW039 Placebo Treatment difference QAW039-placebo
Day

1 395.8 (382.4, 409.2) 390.8 (378.6, 403.0) 4.9 (−13.1, 23.0)NS
2 420.9 (407.7, 434.1) 407.5 (394.4, 420.7) 13.4 (−5.3, 32.0)NS
7 402.9 (388.9, 416.9) 394.0 (381.6, 406.3) 8.9 (−9.7, 27.6)NS
14 414.6 (400.8, 428.3) 382.9 (370.2, 395.5) 31.7 (13.1, 50.3)⁎⁎
21 409.5 (395.2, 423.7) 394.4 (380.9, 407.9) 15.1 (−4.5, 34.7)NS
28 391.0 (376.5, 405.5) 379.9 (367.4, 392.4) 11.1 (−8.0, 30.2)NS

Data are least squares mean, 90% CI.

NS, not significant.

⁎⁎

P<0.01.